Upregulation of SMYD3 and SMYD3 VNTR 3/3 Polymorphism Increase the Risk of Hepatocellular Carcinoma

Scientific Reports - United Kingdom
doi 10.1038/s41598-020-59667-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

SET and MYND Domain Containing 3 (SMYD3)

Science-Business eXchange
2013English

Role of the SMYD3 Histone Methyltransferase in Tumorigenesis

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2012English

Upregulation of E2F Transcription Factor 3 Is Associated With Poor Prognosis in Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2014English

The SMYD3 Methyltransferase Promotes Myogenesis by Activating the Myogenin Regulatory Network

Scientific Reports
Multidisciplinary
2019English

Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2014English

Smyd2 Versus Smyd3: Structure-Based Analysis of Small-Molecule Binding Selectivity

Acta Crystallographica Section A: Foundations and Advances
Materials ScienceCondensed Matter PhysicsTheoretical ChemistryBiochemistryStructural BiologyInorganic ChemistryPhysical
2018English

Smyd3, a Histone Methyltransferase, Modulates the Growth and Differentiation of Human Cardiac Stem Cells

BMC Genomics
BiotechnologyGenetics
2014English

Smyd3 Is Required for the Development of Cardiac and Skeletal Muscle in Zebrafish

PLoS ONE
Multidisciplinary
2011English

Effect of SMYD3 on Biological Behavior and H3K4 Methylation in Bladder Cancer

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy